Sol Net Income From Continuing Ops vs Operating Income Analysis

SLGL Stock

USD 1.65 0.67 68.37%

Sol Gel financial indicator trend analysis is much more than just breaking down Sol Gel Technologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sol Gel Technologies is a good investment. Please check the relationship between Sol Gel Net Income From Continuing Ops and its Operating Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sol Gel Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Net Income From Continuing Ops vs Operating Income

Net Income From Continuing Ops vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sol Gel Technologies Net Income From Continuing Ops account and Operating Income. At this time, the significance of the direction appears to have strong relationship.

The correlation between Sol Gel's Net Income From Continuing Ops and Operating Income is 0.61. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Operating Income in the same time period over historical financial statements of Sol Gel Technologies, assuming nothing else is changed. The correlation between historical values of Sol Gel's Net Income From Continuing Ops and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Sol Gel Technologies are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Net Income From Continuing Ops i.e., Sol Gel's Net Income From Continuing Ops and Operating Income go up and down completely randomly.

Correlation Coefficient

0.61

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Income From Continuing Ops

Operating Income

Operating Income is the amount of profit realized from Sol Gel Technologies operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Sol Gel Technologies is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Sol Gel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sol Gel Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sol Gel Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

The value of Selling General Administrative is expected to slide to about 6.8 M. The value of Issuance Of Capital Stock is estimated to slide to about 18.4 M

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	880K	562K	342K	554.3K
Interest Income	257K	1.3M	1.9M	1.1M

Reconciled Depreciation Interest Income

Sol Gel fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Common Stock Shares Outstanding	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Other Current Liab	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Capital Surpluse
Total Assets		-0.22	0.87	0.84	0.86	-0.85	0.64	0.76	0.41	0.86	-0.19	0.85	1.0	-0.32	0.92	0.83	-0.59	0.63	0.84	-0.66	0.73	-0.63	0.98	0.89	0.79	0.92
Total Current Liabilities	-0.22		-0.67	-0.23	-0.67	0.16	-0.04	0.04	0.18	0.04	1.0	0.15	-0.25	0.99	-0.36	-0.01	0.89	-0.06	-0.03	0.84	0.05	0.84	-0.32	-0.37	-0.23	-0.35
Total Stockholder Equity	0.87	-0.67		0.74	0.98	-0.69	0.54	0.55	0.24	0.61	-0.65	0.54	0.88	-0.74	0.87	0.63	-0.89	0.5	0.64	-0.91	0.52	-0.89	0.89	0.83	0.7	0.84
Other Liab	0.84	-0.23	0.74		0.78	-0.95	0.2	0.71	0.33	0.92	-0.2	0.83	0.83	-0.32	0.96	0.66	-0.55	0.62	0.71	-0.61	0.69	-0.66	0.79	0.93	0.86	0.92
Net Tangible Assets	0.86	-0.67	0.98	0.78		-0.76	0.46	0.55	0.17	0.65	-0.65	0.6	0.87	-0.74	0.89	0.63	-0.9	0.51	0.65	-0.92	0.52	-0.9	0.9	0.9	0.72	0.9
Retained Earnings	-0.85	0.16	-0.69	-0.95	-0.76		-0.22	-0.75	-0.23	-0.96	0.13	-0.93	-0.85	0.24	-0.94	-0.69	0.52	-0.56	-0.73	0.57	-0.64	0.61	-0.81	-0.97	-0.83	-0.96
Accounts Payable	0.64	-0.04	0.54	0.2	0.46	-0.22		0.18	0.11	0.29	-0.03	0.39	0.66	-0.1	0.37	0.62	-0.23	0.15	0.59	-0.23	0.23	-0.17	0.71	0.3	0.27	0.37
Cash	0.76	0.04	0.55	0.71	0.55	-0.75	0.18		0.74	0.79	0.07	0.73	0.72	-0.07	0.72	0.53	-0.36	0.83	0.53	-0.5	0.86	-0.43	0.61	0.71	0.62	0.7
Other Assets	0.41	0.18	0.24	0.33	0.17	-0.23	0.11	0.74		0.34	0.19	0.26	0.35	0.08	0.27	0.24	-0.04	0.78	0.21	-0.21	0.84	-0.07	0.23	0.21	0.26	0.2
Common Stock Shares Outstanding	0.86	0.04	0.61	0.92	0.65	-0.96	0.29	0.79	0.34		0.07	0.95	0.85	-0.04	0.9	0.71	-0.36	0.57	0.74	-0.43	0.68	-0.47	0.79	0.88	0.8	0.89
Total Liab	-0.19	1.0	-0.65	-0.2	-0.65	0.13	-0.03	0.07	0.19	0.07		0.18	-0.22	0.99	-0.33	0.02	0.88	-0.03	0.0	0.82	0.07	0.82	-0.29	-0.34	-0.19	-0.32
Short Long Term Debt	0.85	0.15	0.54	0.83	0.6	-0.93	0.39	0.73	0.26	0.95	0.18		0.84	0.07	0.82	0.76	-0.25	0.51	0.79	-0.31	0.64	-0.33	0.8	0.85	0.74	0.87
Total Current Assets	1.0	-0.25	0.88	0.83	0.87	-0.85	0.66	0.72	0.35	0.85	-0.22	0.84		-0.34	0.92	0.83	-0.61	0.58	0.84	-0.66	0.68	-0.64	0.99	0.89	0.78	0.92
Short Term Debt	-0.32	0.99	-0.74	-0.32	-0.74	0.24	-0.1	-0.07	0.08	-0.04	0.99	0.07	-0.34		-0.44	-0.1	0.93	-0.19	-0.12	0.89	-0.07	0.88	-0.4	-0.45	-0.32	-0.43
Common Stock	0.92	-0.36	0.87	0.96	0.89	-0.94	0.37	0.72	0.27	0.9	-0.33	0.82	0.92	-0.44		0.7	-0.69	0.58	0.73	-0.74	0.62	-0.77	0.89	0.96	0.85	0.96
Property Plant Equipment	0.83	-0.01	0.63	0.66	0.63	-0.69	0.62	0.53	0.24	0.71	0.02	0.76	0.83	-0.1	0.7		-0.32	0.46	1.0	-0.36	0.63	-0.42	0.83	0.7	0.83	0.74
Short Long Term Debt Total	-0.59	0.89	-0.89	-0.55	-0.9	0.52	-0.23	-0.36	-0.04	-0.36	0.88	-0.25	-0.61	0.93	-0.69	-0.32		-0.36	-0.34	0.98	-0.28	0.97	-0.64	-0.7	-0.53	-0.69
Other Current Liab	0.63	-0.06	0.5	0.62	0.51	-0.56	0.15	0.83	0.78	0.57	-0.03	0.51	0.58	-0.19	0.58	0.46	-0.36		0.48	-0.49	0.91	-0.41	0.5	0.57	0.66	0.56
Property Plant And Equipment Net	0.84	-0.03	0.64	0.71	0.65	-0.73	0.59	0.53	0.21	0.74	0.0	0.79	0.84	-0.12	0.73	1.0	-0.34	0.48		-0.37	0.63	-0.44	0.85	0.73	0.86	0.77
Net Debt	-0.66	0.84	-0.91	-0.61	-0.92	0.57	-0.23	-0.5	-0.21	-0.43	0.82	-0.31	-0.66	0.89	-0.74	-0.36	0.98	-0.49	-0.37		-0.41	0.97	-0.67	-0.74	-0.57	-0.72
Non Current Assets Total	0.73	0.05	0.52	0.69	0.52	-0.64	0.23	0.86	0.84	0.68	0.07	0.64	0.68	-0.07	0.62	0.63	-0.28	0.91	0.63	-0.41		-0.34	0.6	0.63	0.68	0.62
Non Currrent Assets Other	-0.63	0.84	-0.89	-0.66	-0.9	0.61	-0.17	-0.43	-0.07	-0.47	0.82	-0.33	-0.64	0.88	-0.77	-0.42	0.97	-0.41	-0.44	0.97	-0.34		-0.66	-0.76	-0.67	-0.74
Cash And Short Term Investments	0.98	-0.32	0.89	0.79	0.9	-0.81	0.71	0.61	0.23	0.79	-0.29	0.8	0.99	-0.4	0.89	0.83	-0.64	0.5	0.85	-0.67	0.6	-0.66		0.88	0.77	0.91
Common Stock Total Equity	0.89	-0.37	0.83	0.93	0.9	-0.97	0.3	0.71	0.21	0.88	-0.34	0.85	0.89	-0.45	0.96	0.7	-0.7	0.57	0.73	-0.74	0.63	-0.76	0.88		0.83	1.0
Non Current Liabilities Total	0.79	-0.23	0.7	0.86	0.72	-0.83	0.27	0.62	0.26	0.8	-0.19	0.74	0.78	-0.32	0.85	0.83	-0.53	0.66	0.86	-0.57	0.68	-0.67	0.77	0.83		0.83
Capital Surpluse	0.92	-0.35	0.84	0.92	0.9	-0.96	0.37	0.7	0.2	0.89	-0.32	0.87	0.92	-0.43	0.96	0.74	-0.69	0.56	0.77	-0.72	0.62	-0.74	0.91	1.0	0.83

Click cells to compare fundamentals

Sol Gel Account Relationship Matchups

Sol Gel fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	61.3M	59.2M	69.2M	46.6M	45.3M	42.7M
Total Current Liabilities	6.5M	6.0M	11.7M	3.3M	4.5M	4.3M
Total Stockholder Equity	52.5M	50.8M	55.6M	42.2M	38.6M	22.6M
Other Liab	958K	1.0M	1.1M	1.0M	1.2M	959.7K
Net Tangible Assets	52.5M	50.8M	55.6M	42.2M	48.5M	51.0M
Retained Earnings	(152.1M)	(181.4M)	(178.1M)	(193.1M)	(220.3M)	(209.3M)
Accounts Payable	1.7M	1.2M	766K	251K	154K	146.3K
Cash	9.4M	7.1M	20.1M	12.4M	7.5M	8.8M
Other Assets	1.2M	2.0M	9.5M	2.0M	1.0	0.95
Common Stock Shares Outstanding	19.5M	22.6M	23.6M	23.1M	27.1M	19.9M
Total Liab	8.8M	8.3M	13.6M	4.4M	6.6M	6.3M
Total Current Assets	55.8M	53.4M	57.1M	43.1M	41.2M	37.7M
Common Stock	520K	561K	635K	638K	774K	450.3K
Property Plant Equipment	4.4M	3.7M	2.6M	1.5M	1.8M	2.4M
Other Current Liab	4.1M	3.4M	9.4M	1.6M	3.9M	3.8M
Property Plant And Equipment Net	4.4M	3.7M	2.6M	1.5M	2.2M	2.5M
Net Debt	(7.4M)	(5.2M)	(18.5M)	(11.7M)	(5.9M)	(5.6M)
Non Current Assets Total	5.5M	5.8M	12.1M	3.6M	4.1M	5.4M
Non Currrent Assets Other	684K	754K	830K	749K	681K	930.3K
Cash And Short Term Investments	50.4M	50.2M	43.2M	33.6M	38.0M	36.7M
Liabilities And Stockholders Equity	61.3M	59.2M	69.2M	46.6M	45.3M	47.2M
Non Current Liabilities Total	2.3M	2.3M	1.9M	1.1M	2.1M	1.6M
Other Current Assets	1.3M	1.1M	800K	1.5M	2.8M	1.9M
Other Stockholder Equity	204.0M	231.6M	233.1M	234.6M	258.2M	179.2M
Property Plant And Equipment Gross	4.4M	3.7M	2.6M	7.3M	8.0M	8.4M
Short Term Investments	41.0M	43.1M	23.2M	21.2M	30.5M	25.2M
Net Invested Capital	52.5M	50.8M	55.6M	42.2M	38.6M	49.7M
Net Working Capital	49.3M	47.4M	45.4M	39.7M	36.6M	35.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Sol Gel Technologies is a strong investment it is important to analyze Sol Gel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sol Gel's future performance. For an informed investment choice regarding Sol Stock, refer to the following important reports:

How To Invest In Sol

Details

Is Sol Stock a good investment?

Details

What is Sol Gel's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sol Gel Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sol Gel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.34)

Revenue Per Share

0.235

Quarterly Revenue Growth

8.146

Return On Assets

(0.22)

Return On Equity

(0.36)

The market value of Sol Gel Technologies is measured differently than its book value, which is the value of Sol that is recorded on the company's balance sheet. Investors also form their own opinion of Sol Gel's value that differs from its market value or its book value, called intrinsic value, which is Sol Gel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sol Gel's market value can be influenced by many factors that don't directly affect Sol Gel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sol Gel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sol Net Income From Continuing Ops vs Operating Income Analysis

Net Income From Continuing Ops vs Operating Income

Net Income From Continuing Ops vs Operating Income Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Operating Income

Sol Gel fundamental ratios Correlations

Sol Gel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sol Gel fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Property Plant And Equipment Net	+ 1.0	Property Plant Equipment
Capital Surpluse	+ 1.0	Common Stock Total Equity
Short Term Debt	+ 0.99	Total Current Liabilities
Short Term Debt	+ 0.99	Total Liab

Common Stock Total Equity	- 0.97	Retained Earnings
Capital Surpluse	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.96	Retained Earnings
Retained Earnings	- 0.95	Other Liab
Common Stock	- 0.94	Retained Earnings
Short Long Term Debt	- 0.93	Retained Earnings